XML 54 R38.htm IDEA: XBRL DOCUMENT v3.21.1
Acquisition of Novavax CZ - Supplemental Pro Forma Financial Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Proforma financial information:    
Revenue $ 447,229 $ 3,377
Net loss $ (222,719) $ (27,625)
Basic and diluted net loss per share (in dollars per share) $ (3.05) $ (0.53)